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Profilins belong to a family of G-actin binding proteins which are thought to facilitate actin 
polymerization at the leading edge of migrating cells via its polyproline interactions with major 
actin nucleating and F-actin elongating proteins. The two major goals of this study are i) to 
spatially resolve profilins-1’s (the only ubiquitously expressed member of profilin family) 
interaction with Ena (enabled)/VASP (vasodilator stimulated phosphoprotein) family of F-actin 
elongating protein, and ii) determine whether Ena/VASP regulates cell migration through its 
interaction with profilin-1.. This study demonstrates the feasibility of GFP (green fluorescence 
protein)-based florescence resonance energy transfer (FRET) to identify profilin-1 and VASP 
interaction. Through acceptor photobleaching FRET (fluorescence resonance energy transfer) in 
MDA-MB-231 human breast cancer cells, we show that VASP and profilin-1 interaction at the 
membrane ruffles near the leading edge. We further show that VASP overexpression in breast 
cancer cells results in slower random cell motility; however VASP-induced suppression of cell 
motility is partly rescued when VASP:profilin-1 interaction is downregulated These data suggest 
VASP utilizes profilin-1 to regulate breast cancer cell migration.  
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1.0  INTRODUCTION 
1.1 CELL MIGRATION 
Cell migration serves an important role in both physiological and pathological processes 
ranging from embryonic development, angiogenesis (formation of new blood vessels) to tumor 
metastasis [Clainche and Carlier, 2008]. Learning about the mechanisms of how cells migrate is 
crucial to understanding many life processes. Migration of cells can be summarized in four steps 
(schematically represented in Figure 1). Cells must first polarize via cues from external factors 
(such as growth factors like epidermal growth factor or platelet-derived growth factor) or the 
microenvironment  (extracellular matrix) [Panetti et al., 2004]. Once cellular asymmetry is 
established, F-actin polymerization at the front of the cell will create the pushing force against 
the cell membrane to cause membrane protrusion leading to the formation of a flat sheet-like 
structure called lamellipodia [Clainche and Carlier, 2008]. Actin polymerizes on the barbed or 
plus end of filament and depolymerizes at the pointed or minus end. This is known as actin 
treadmilling; faster treadmilling leads to faster protrusion. Five basic requirements must be met 
in order to maximize actin-based protrusions: sufficient G-actin, new actin “nuclei” generation 
(the beginning of an actin filament), efficient F-actin elongation, prevention of undesired growth 
of filaments, and nucleotide (ADP-to-ATP) exchange on  actin monomers.  
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Figure 1. Four step schematic diagram of cell migration: protrusion, adhesion, contraction, and de-adhesion. 
 
The first requirement for effective actin-based motility is having enough G-actin. This 
means having enough G-actin around to add to filaments. Thymosin β4 is a G-actin sequestering 
protein which holds G-actin and prevents it from polymerizing or nucleating, thus some actin is 
always available. Actin nucleation (the process describing the formation of stable actin 
oligomers that is capable of supporting further elongation) is catalyzed by Arp2/3 (actin-related 
protein) complex following its activation by WASP (Wiskott-Aldrich Syndrome Protein) family 
proteins [Tomasevic et al., 2007; Stradal and Scita, 2006]. Elongation of actin filaments is driven 
by formin (also a potent actin nucleator) and Ena/VASP family proteins. Since excessively long 
actin filaments tend to buckle and result in  unproductive protrusions, F-actin elongation can be 
limited by the action of barbed-end capping proteins (example: CapZ) [note that capping also 
funnels actin monomers to those actin filaments which produce productive forces or allows for 
actin monomer use in Arp 2/3 nucleation]. Finally, actin must be regenerated in order for more 
polymerization to occur. Cofilin is an F-actin depolymerizing protein that binds with high 
affinity to ADP-actin (on the minus end) and induces a higher rate of actin depolymerization. 
Membrane altering enzymes such as phospholipase C-γ (PLCγ) and phosphatidylinositol 3-
 3 
kinase (PI3K) are activated downstream of receptor tyrosine kinases (RTKs) leading to the 
release of phospholipid-bound ABPs such as cofilin [Pollard et al., 2003; Rheenen et al., 2007]. 
Once ADP-actin has been detached, profilin-1 (Pfn1) works to facilitate ADP to ATP exchange on 
G-actin and also shuttles ATP-actin to the growing ends of F-actin. Once again, these five basic rules 
maximize actin treadmilling which in turn induces faster protrusion or overall net migration of cells. 
A summary of actin filament/nucleation elongation is shown in Figure 2. 
 
Figure 2. Actin nucleation/elongation model of actin assembly. Starting with an actin filament, first a signal 
will activate Rac/cdc42 which initiates a nucleation promoting factor (such as N-WASP). N-WASP then 
activates Arp2/3 which nucleates actin and begins a new branch on the existing F-actin. Elongating factors 
such as Ena/VASP or formins begin elongating new F-actin branch. Capping protein caps the growing 
filament which then leads to nucleation of the filament again and creates a network of branching filaments. 
To keep a high level of G-actin available, ADP-actin is disassembled either by itself or through cofilin. 
Profilin then changes ADP-actin to ATP-actin and shuttles ATP-actin to the plus ends actin filaments. 
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Once the cells have protruded, new attachments have to be made to ECM (extracellular 
matrix), i.e. basal lamina, connective tissue, through intergrins (integrins are connected to actin 
filaments inside cells by intracellular proteins such as talin or vinculin). Integrins can also bind to 
other cytosolic structures such as focal adhesion kinases (FAK) and Src family kinases to 
mediate actin adhesion dynamics. Creation of new adhesions works to secure protrusions in 
order to create a net movement [Ridley et al., 2003; Sheetz et al., 1999]. Without creation of new 
focal adhesions, protrusions will retract and no net movement will occur. 
While the leading edge is still attached, there must be contraction followed by de-
attachment of focal adhesions at the rear end. Myosin II (actin based protein in non-muscle 
eukaryotic cells) provides the contractile force which allows the rear of the cell to move towards 
the front [Sheetz et al., 1999]. Repeating these steps in a directional manner over a period of time 
will lead to net migration.   
Since membrane protrusion is the defining step of cell migration, much work has focused 
on understanding the molecular controls of actin polymerization. Actin polymerization at the 
leading edge has been studied extensively by biomimetic assays examining F-actin driven 
bacterial pathogen movement (Listeria or Shigella) in either intact host cells or cellular extracts 
or reconstituted system consisting of purified proteins. It was shown that cofilin, capping protein, 
and Arp2/3 are absolutely essential for actin-based Listeria movement. Ena/VASP and Pfn1, 
although not essential, profoundly enhance the velocity of Listeria pathogen [Loisel et al., 1999; 
Geese et al., 2002]. Repeats of these experiments using N-WASP coated beads also show the 
same outcome [Weisner et al., 2003]. N-WASP mediated Shigella movement, on the other hand, 
has been shown to absolutely require Pfn1 [Mimuro et al., 2000].  
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Proteins of the N-WASP, Ena/VASP, or formin family all share a common feature: the 
ability to bind to Pfn1 via proline-rich domains [Witke, 2004].  Nucleation and polymerization 
from activation of WASP, VASP and formin protein families require Pfn1 and Pfn1’s ability to 
interact with G-actin in order to maintain full function.  
1.2 PROFILIN-1 
There are four types of profilin found in the mammalian genome, profilin1-4. Pfn1 (a 
ubiquitously expressed member of profilin and the main focus of this thesis) is found in all cell 
types except skeletal muscle tissue; Pfn2, which is mainly expressed in the cells of neural tissues; 
Pfn3 (found only in kidney and testis) and Pfn4 (only in testis) [Jockusch, 2007]. Pfn1 was 
initially discovered as a G-actin sequestering protein similar to thymosin β4 [Carlsson et al., 
1977]; however, cellular concentration of Pfn1 was found to be insufficient to account for G-
actin concentration in cells.  Although binding to Pfn1 inhibits G-actin incorporation at the 
pointed end of actin filaments, Pfn1 is able to shuttle G-actin to the barbed ends of actin 
filaments. Pfn1 also facilitates the nucleotide exchange on actin (from ADP to ATP) and finally, 
Pfn1 displays affinity for polyproline (PLP) ligands including all major actin-nucleators (WASP, 
WAVE, formins) and elongating proteins (Ena/VASP, formin). These properties enable Pfn1 to 
facilitate actin polymerization rather than inhibit actin polymerization, as initially thought at the 
time of its discovery [Carlsson et al., 1977; Goldschmidt-Clermont et al., 1990; Pantaloni et al., 
1993; Schluter et al., 1997; Kang et al., 1999; Bubb et al., 2003; Witke et al., 2004]. Reducing 
levels of Pfn1 expression led to decreased level of F-actin in various cells which further 
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solidifies Pfn1’s role as a promoter of actin polymerization [Ding et al., 2006; Zou et al., 2007; 
Ding et al., 2009]. 
In addition to binding to actin and polyproline ligands, Pfn1 also binds to the plasma 
membrane by interactions with phosphoinositides (PPIs) such as phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2), phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2; formed from 
dephosphorylation of PIP3 by PI-5-phosphatase) and phosphatidylinositol-3,4,5-triphosphate 
(PIP3; formed from the phosphorylation of PI(4,5)P2 by PI3K). Phosphoinositide 3-kinase 
(PI3K) activation forms PI(3,4)P2 and PIP3 [Lu et al., 1996]. With two PPI binding regions (for 
mammalian Pfn1), one overlapping the actin-binding domain and the other slightly overlapping 
the PLP binding domain, Pfn1-PPI binding has been theorized to prevent interaction with actin 
[Lassing et al., 1985; Skare et al., 2002].  
1.3 PROFILIN-1 AND CELL MIGRATION 
A study on Dictyostelium ameba lacking Pfn1 and Pfn2 showed a severe defect in cell 
migration [Haugwitz et al., 1994]. Drosophila with Pfn1 mutations also exhibited defects in 
development [Verheyen and Cooley, 1994]. Furthermore, C. elegans require Pfn1 for 
embryogenesis [Velarde, 2007]. Silencing Pfn1 expression dramatically suppresses vascular 
endothelial cell motility [Ding et al., 2006; Ding et al., 2009]. Together these studies demonstrate 
Pfn1’s role in cell migration. Pfn1’s involvement in Listeria movement, preferential localization 
of Pfn1 at the leading edge and defects in protrusion resulting from Pfn1 depletion in vascular 
endothelial cells suggest that one of the main functions of Pfn1 is to regulate actin 
polymerization at the leading edge and thereby facilitate membrane protrusion and overall cell 
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migration [Buss et al., 1992; Mayboroda et al., 1997; Neely and Macaluso, 1997; Suetsugu et al., 
1998; Mimuro et al., 2000]. Mutagenesis-based studies have shown that Pfn1’s interaction with 
both actin and PLP ligands is important for membrane protrusion and overall migration of 
vascular endothelial cells [Ding et al., 2006; Ding et al., 2009]. This is consistent with a 
previously proposed hypothesis that PLP ligands may act to spatially regulate the location of 
Pfn1-actin complexes to the leading edge where actin polymerization takes place during cell 
migration [Holt et al., 2001].  
In stark contrast to these findings, breast cancer cells and normal human mammary 
epithelial cells display faster migration when Pfn1 expression is silenced and overexpression of 
Pfn1 suppresses breast cancer cell motility [Zou et al., 2007; Bae et al., 2009]. Many invasive 
adenocarcinomas have low levels of Pfn1 when compared to their non-tumorigenic counterparts 
[Janke et al., 2000; Belot et al., 2002; Wittenmayer et al., 2004; Gronborg et al., 2006]. These 
data might suggest that Pfn1 has a context-specific role in cell migration. Recently, our group 
has shown that Pfn1 inhibits breast cancer cell motility through its membrane phosphoinositide 
interaction and this is independent of its actin-related activity [Bae et al., 2009]. 
1.4  ENA/VASP 
Ena/VASP family proteins consist of three members, Drosophila Enabled (Ena, or 
Mammalian Enabled, Mena, in mammals), VASP (the focus Ena/VASP protein for the thesis), 
and Ena-VASP-like (EVL), all of which have been identified as regulators of actin 
polymerization and cell migration [Krause et al., 2003]. Conserved in the Ena/VASP family are 
the EVH1 (Ena/VASP homology 1) domain, proline-rich domain, and EVH2 (Ena/VASP 
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homology 2) domain, all of which are schematically represented in Figure 3. EVH1 domain 
binds to consensus site FPPPP found in focal adhesion proteins such as Zyxin, phagocytic cups 
of macrophages, and to Listeria through ActA [Krause et al., 2003]. Through this domain, 
Ena/VASP is recruited to focal adhesions and to the membrane as well. 
The EVH2 domain contains a G-actin binding site, F-actin binding site, and a coiled-coil 
motif which allows for tetramerization of Ena/VASP proteins [Gertler et al., 1996; Bachmann et 
al., 1999]. The tetramerization of Ena/VASP family proteins via the coiled-coil domain has been 
shown in vitro to enhance actin binding and bundling [Bachmann et al., 1999; Walders-Harbeck 
et al., 2002]. EVH2 allows VASP to act as the actin elongator by allowing it to bind to F-actin 
and bring G-actin to the growing barbed end. This elongation at the barbed end has also led 
VASP to be considered as an anti-capper as it competes with capping proteins at the barbed ends 
of F-actin [Bear et al., 2002]. 
 
 
Figure 3. Conserved domains of Ena/VASP 
 
Finally, the proline-rich domain of Ena/VASP contains sites for SH3 (Abl, Src, etc.) and 
WW (Utrophin, etc.) binding and for the protein Pfn1 [Krause et al., 2003]. This domain contains 
3 distinct regions, a regulatory GPPPPP (GP5) site, three recruiting GP5 sites, and a loading site 
(schematically represented in Figure 3). The regulatory and recruiting sites recruit Pfn1 to the 
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proline domain with low affinity while the loading site recruits Pfn1 with 10-fold higher affinity 
[Ferron et al., 2007]. Recruitment of Pfn1 to the proline domain allows Ena/VASP to function at 
maximum capacity, at least in terms of its actin polymerizing ability and anti-capping function 
[Barzik et al., 2005; Hansen et al., 2010]. 
Like Pfn1, Ena/VASP has a context specific effect in cell migration. While speed of 
rapidly migrating fish keratocytes is correlated with leading edge localization of Ena/VASP 
proteins [Lacayo et al., 2007], fibroblast motility show the exactly opposite phenotype [Bear et 
al., 2000]. However, in both cell types, Ena/VASP acts as a positive regulator of membrane 
protrusion. This is consistent with Ena/VASP’s positive effect on Listeria speed. Motility 
analyses of  Ena/VASP null cells following rescue with wild-type or various deletion mutants of 
Ena/VASP revealed that EVH2 domain is critical but the polyproline domain of Ena/VASP  is 
dispensable for,  at least, whole cell migration. However, Ena/VASP-promoted Listeria motility 
is significantly diminished when its entire polyproline domain is deleted. Note that when GP5 
sites alone were deleted leaving the loading polyproline site intact, the effect on Listeria motility 
was modest thus suggesting loading polyproline site interaction may be the predominant site 
[Geese et al., 2002]. Since Pfn1 binds to loading polyproline site with high affinity, it could be 
speculated that Ena/VASP regulates Listeria motility through its interaction with Pfn1 – 
however, this has not been directly demonstrated.  
Given that Listeria motility has been conceived as a molecular mimicry of actin-based 
membrane protrusion in migrating cells, why polyproline domain deletion of Ena/VASP alters 
Listeria speed but has no effect on overall cell migration is not clear.   Also since polyproline 
domain of Ena/VASP can bind SH3 and WW-domain proteins besides Pfn1, the role of 
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Ena/VASP’s interaction specifically with Pfn1 in cell migration still remains unsettled in 
experiments utilizing deletion of polyproline domain. This will be the focus of this thesis. 
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2.0  HYPOTHESIS AND SPECIFIC AIMS 
Ena/VASP plays a critical role in controlling actin filament geometry, membrane 
protrusion and the overall regulation of cell motility [Pollard et al., 2003]. Although biochemical 
studies have shown that Pfn1 enhances actin polymerizing and anti capping ability of Ena/VASP 
in vitro [Barzik et al., 2005; Hansen et al., 2010], the in vivo significance of Pfn1’s interaction 
with Ena/VASP is somewhat unclear.  While a functional polyproline domain of Ena/VASP was 
shown to be required for Listeria motility (a biomimetic readout of actin polymerization at the 
leading edge of migrating cells), it was dispensable for whole cell migration, at least in the case 
of fibroblasts. Conclusions of these studies were based on the effect of deleting the polyproline 
domain of Ena/VASP which not only abrogates its binding to Pfn1, but may potentially affect 
Ena/VASP’s interaction with SH3- and WW-domain containing proteins. Therefore, there is a 
need to revisit these studies specifically investigating the contribution of Pfn1’s interaction in 
Ena/VASP-mediated regulation of cell migration. Another limitation in the field is that 
Ena/VASP’s interaction with Pfn1 has been studied almost exclusively using biochemical 
approaches; therefore spatiotemporal aspects of this interaction during cell migration remains 
unknown. I hypothesize that “Ena/VASP regulates cell migration through its interaction with 
Pfn1 and Ena/VASP:Pfn1 interaction has a spatial bias in migrating cells”. To test this 
hypothesis, I will: 
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Specific Aim 1: Determine the spatial location of Ena/VASP:Pfn1 interaction by 
FRET in migrating cells (MDA-MB-231). 
 
Specific Aim 2: Determine whether Ena/VASP’s effect on cell motility is influenced by 
its interaction with Pfn1.  
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3.0  MATERIALS AND METHODS 
3.1 PLASMID CONSTRUCTION AND SIRNAS 
GFP-Pfn1 generation has been previously described [Roy et al., 2004]. To generate YFP-
Pfn1, Pfn1 was excised from EGFP-Pfn1 vector and subcloned into EYFP-C1 vector at Hind3 
and BamH1 restriction. YFP-Pfn1 was also subcloned into ECFPN1 vector at EcorR1 and Kpn1 
restriction sites to generate the chimeric YFP–Pfn1–CFP (YPC) construct. Myc-tagged YFP-
Pfn1 construct (myc-YFP-Pfn1) was generated by subcloning YFP-Pfn1 into a pCMV-myc 
expression vector at EcoR1 and Kpn1 restriction sites. Full-length VASP cDNA (PCR amplified 
from a human cDNA library) was subcloned into ECFP-C1 vector at Hind3 and BamH1 
restriction sites. Pfn1-shRNA was constructed by ligating a commercially available vector pRFP-
C-RS (Origene Technologies Inc., Rockville, MD) with a custom-designed 21-mer hairpin 
sequence targeting Pfn1 at BamH1 and Hind3 sites. The sense sequence for the Pfn1-shRNA is 
5’-GAT CGA AGA AGG TGT CCA CGG TGG TTA AGT TCT CTA ACC ACC GTG GAC 
ACC TTC TTT TTT TTG GAA A-3’; the antisense sequence is 5’-AGC TTT TCC AAA AAA 
AAG AAG GTG TCC ACG GTG GTT AGA GAA CTT AAC CAC CGT GGA CAC CTT CTT 
C 3’. A control shRNA vector against luciferase (luc-shRNA) was also constructed in the same 
manner with the sense sequence: 5’-GAT CGG CTT ACG CTG AGT ACT TCG ATT CAA 
GAG ATC GAA GTA CTC AGC GTA AGC TTT TTT GGA AA-3’, and the antisense 
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sequence: 5’-AGC TTT TCC AAA AAA GCT TAC GCT GAG TAC TTC GAT CTC TTG 
AAT CGA AGT ACT CAG CGT AAG CC-3’. H133S mutation in Pfn1-coding region of YFP-
Pfn1 and myc-YFP-Pfn1 was executed by site-directed mutagenesis as previously described 
[Zou et al., 2007].  All Pfn1 constructs were made Pfn1-siRNA-resistant by placing a silent 
mutation in the siRNA targeting region without changing the peptide encoding (targeting region 
of Pfn1-siRNA has been previously described [Ding et al., 2009]). VASP siRNA targeted to the 
untranslated region (GAGUGAAUCUGCGCGGAGA), UTR, and Mena siRNA targeted to the 
open reading frame (GAGAGAGAGCGCAGAAUAU), ORF, were purchased from Dharmacon 
(Lafayette, CO). Mutagenesis of enhanced green fluorescent protein (EGFP)-tagged full length 
VASP regulatory GP5 site P120 and loading site L210 was done using PCR-based site-directed 
mutagenesis.  The forward and reverse primers for P120E mutant were 5’ - GGA GGT GGG 
CCC CCT GAA CCC CCA GCA CTT CCC - 3’ and 5’ – GGG AAG TGC TGG GGG TTC 
AGG GGG CCC ACC TCC - 3’ respectively. The forward and reverse primers for L210E 
mutant were 5’ – CCC CCT GCA CCC CCT GAA CCG GCA GCA CAG GGC - 3’ and 5’ – 
GCC CTG TGC TGC CGG TTC AGG GGG TGC AGG GGG - 3’ respectively. EGFP-VASP 
with regulatory and loading site mutations was made as follows. EGFP-VASP was first mutated 
at P120 and then that modified vector was mutated at L210. All constructs were confirmed by 
DNA sequencing. 
3.2 CELL CULTURE AND TRANSFECTION 
HEK293 cells were cultured in DMEM-F12 media supplemented with 10% fetal bovine 
serum (FBS) and antibiotics (Invitrogen - Carlsbad, CA). MDA-231 breast cancer cells were 
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cultured in EMEM media and supplemented with 10% FBS, sodium pyruvate and antibiotics. 
MDA-231 stably transfected with Pfn1- and Luc shRNA were selected and maintained as stated 
above with additional 250 ng/mL puromycin. MDA-231 cells stably transfected with EGFP or 
EGFP VASP constructs using Lipofectamine 2000 reagent (Invitrogen- Carlsbad, CA) were 
maintained in media as above and supplemented with 500 μg/ml G418. The working 
concentration for various siRNAs were: Pfn1 (50 nM for MDA-231) , VASP (100 nM), and 
Mena (100 nM). SiRNA transfection was performed using reagents commercially available from 
Dharmacon (Lafayette, CO) following the manufacturer’s protocol. All silencing-based 
experiments were performed 72 hours after transfection. 
3.3 ANTIBODIES 
Monoclonal GFP (1:1000), VASP (1:1000) and vimentin (1:1000) antibodies were 
obtained from Pharmingen (San Diego, CA). Polyclonal GFP antibody was obtained from 
Abcam (Cambridge, MA). Polyclonal VASP antibody was obtained as a generous gift from Dr. 
Frank Gertler (MIT; Cambridge, MA). Polyclonal Pfn1 (1:1000) and monoclonal Mena (1:200) 
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal 
GAPDH (1:2000) antibody was obtained from Abd Serotec (Raleigh, NC). Polyclonal myc 
(1:2000) antibody was obtained from Sigma Aldrich (St. Louis, MO).  
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3.4 PROTEIN EXTRACTION / IMMUNOBLOTTING 
Total cell lysate (TCL) was prepared by first washing cells with cold DPBS and then 
extracting cells with modified RIPA buffer (50 mM Tris-HCL—pH 7.5, 150 mM NaCl, 1% 
triton-X100, .25% sodium deoxycholate, 0.1% SDS, 2 mM EDTA, 50 mM NaF, 1 mM sodium 
pervanadate, 10 µg/mL leupeptin, aprotinin, pepstatin and 1 mM phenylmethylsulfonyl fluoride. 
The lysates were clarified at 13,000 rpm for 10 min at 4 oC and the protein concentration was 
determined using a coomassie-based protein assay kit (Pierce; Rockford, IL). For protein 
electrophoresis, equal amounts of protein samples were loaded on a SDS-PAGE and transferred 
onto a nitrocellulose membrane. After blocking the membrane with 5% non-fat dry milk in 
TBST for 1 hour at room temperature, immunoblotting was performed overnight with the 
appropriate antibodies. After extensive washing with TBST, the blot was incubated with the 
appropriate secondary antibody (1:1000 dilution, Pharmingen, San Diego, CA) and washed 3 
times with TBST before performing chemiluminescence for the visualization of protein bands.  
3.5 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 
For spectral FRET analyses, cells expressing FRET constructs (YFP-Pfn1:CFP-VASP, 
YFP-Pfn1 H133S:CFP-VASP, YPC) were trypsinized and resuspended in PBS before an 
emission scan was performed on cell suspension for a wavelength range of 465–600 nm 
corresponding to 425 nm excitation using a spectrofluorophotometer (spectral scan was gathered 
within 10 min of trypsinization). For imaging experiments, cells expressing various FRET 
constructs were allowed to form a monolayer on collagen coated glass cover slips and then 
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scratched using a pipet-tip. Cells migrated for 6–8 h before fixing them with 4% formaldehyde 
for 15 minutes, washed with DPBS after, and then mounted on slides. Acceptor photobleaching 
was then performed on cells that display polarized morphology (these cells are typically located 
on the edge of the wound and tend to be most motile before fixation) on a Zeiss LSM 510 Meta 
confocal microscope (Carl Zeiss. Inc., Thornwood, NY) coupled to an argon laser. Cells were 
bleached at the region of interest (ROI) with 514 nm wavelength on 50% laser power, and the 
bleaching duration ranged from 10 to 20 s (for ROI bleaching) to ~1 min (for whole cell 
bleaching). Cells were imaged with a 63x 1.4 NA Zeiss oil immersion objective at either 2x or 
4x zoom. CFP and YFP images were acquired with laser power set at 33% (458 nm) and 7.5% 
(488 nm), respectively. To calculate FRET efficiency, multiple 120-pixel long lines within ROI 
were constructed from the edge of the cell into the cytoplasm; the average intensity of these line 
scans in CFP channel before bleaching was subtracted from the corresponding value recorded 
after bleaching and then normalized to the pre-bleaching value. 
3.6 SINGLE-CELL MIGRATION ASSAY 
MDA-231 with different treatments, were sparsely plated (1.5-3.5 x 104 cells) on a 35 
mm plastic tissue-culture dish coated with collagen. After incubation overnight, time-lapse 
videomicroscopy of 9 random phase contrast fields with 10x objective were simultaneously 
performed at an interval of 1 minute for a total duration of 120 minutes. For all time-lapse 
imaging, optimal environmental conditions, 37°C and pH 7.4, were maintained by a 
microincubator. Cell trajectory was built via frame-by-frame analyses of the centroid positions 
(x, y) of cell-nuclei (which were assumed to be the fair representation of the cell body). 
 18 
Protrusion direction was determined by creating a vector from the centroid of a cell-nuclei and 
the furthest point of a protrusion before protrusion is retracted. Persistence was calculated using 
a non-overlapping interval random walk model as previously described [Dickenson and 
Tranquillo, 2004] The acquired images were analyzed using the NIH ImageJ software. 
3.7 STATISTICS AND DATA REPRESENTATION 
All statistical tests were performed with ANOVA followed by Tukey-Kramer post-hoc 
test analysis. P values less than 0.05 were considered to be statistically significant. In most cases, 
experimental data was represented as box and whisker plots where crosses represents the mean, 
middle lines of box indicates median, top of the box indicates 75th percentile, bottom of the box 
measures 25th percentile and the two whiskers indicate the 10th and 90th percentiles, 
respectively. 
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4.0  SPATIAL INTERACTION OF PFN1 AND VASP 
From previous experiments, we have learned that Pfn1 is important in motility. For example, 
there is evidence of motility defect when Pfn1 and 2 are suppressed in Dictyostelium amebae 
[Haugwitz et al., 1994]. In addition, Drosophila expressing a mutant Pfn1 [Verheyen et al., 
1994] and Pfn1 deficient human vascular endothelial cells [Ding et al., 2006] show defects in 
cell migration. These effects, however, depend on the cell type as silencing Pfn1 in invasive 
breast cancer cells increase cell motility while overexpression leads to a reduction in cell motility 
[Roy et al., 2004; Zou et al., 2007; Bae et al., 2009]. Pfn1 interaction with PLPs has also been 
shown to be important for cell migration [Ding et al., 2006; Ding et al., 2009] but specific 
interaction has never been shown.  
 
Specific Aim 1: To determine spatially where Pfn1 and VASP interact in motile cells 
(human breast cancer cells) 
 
This chapter has been published in the following: 
Gau, D, Ding Z, Baty C, Roy P. (2011) Fluorescence Resonance Energy Transfer (FRET)-
based detection of profilin-VASP interaction. Cell. Mol. Bioeng. 4, 1-8.  
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4.1 RESULTS 
4.1.1 Generation of FRET constructs 
Pfn1 interaction with Ena/VASP has been investigated in the past using biochemical 
techniques; however biochemical techniques [Reinhard et al., 1995] do not allow for spatial 
recognition of where the protein-protein interaction takes place. To show where Pfn1:VASP 
interaction take place, we utilized a technique called fluorescence resonance energy transfer 
(FRET). FRET utilizes energy transfer from one excited fluorescent molecule (designated as the 
donor) to another close and unexcited fluorescent molecule (designated as the acceptor) such that 
the acceptor will emit a fluorescent signal and the emission signal of the donor decreases. When 
two proteins that are potentially interacting with each other are conjugated with donor and 
acceptor fluorophores, the association may be visualized by FRET [Roy et al., 2002]. Note that 
the work done in the next three figures was performed by Dr. Partha Roy. 
First and foremost, CFP and YFP FRET pair constructs were generated and schematically 
represented in Figure 4a (CFP is fused to VASP while YFP is fused to Pfn1). CFP and YFP 
(CFP and YFP are a suitable FRET pair as CFP excitation level is distinct from YFP excitation 
however CFP emission will excite YFP) conjugated to VASP and Pfn1 respectively were created 
via N-terminus fusion. Fusion of GFP to the N-terminus typically roughly creates a 50% 
reduction in polyproline binding but no side effects to actin or phospholipid binding of Pfn1 
[Gau et al., 2011]. Despite the reduction of polyproline binding due to GFP conjugation, this is 
an acceptable strategy as fusion of GFP to the C-terminus abolishes Pfn1’s ability to bind 
polyproline. In addition, GFP-Pfn1 has been shown to still localize in similar regions as 
endogenous Pfn1 while Pfn1-GFP does not [Wittenmayer et al., 2000]. It has also been 
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previously shown that GFP binding to the N-terminus of VASP has been used as a live-cell 
reporter for VASP [Rottner et al., 1999]. Additionally, an H133S point mutation form of Pfn1 
was generated on YFP-Pfn1 as a negative control. This mutant should have very little to no 
binding ability to any PLPs including VASP [Zou et al., 2007]. In addition to the CFP and YFP 
tag, myc-tag was introduced to the YFP constructs which enables specific immunoprecipitation 
of YFP-Pfn1 and YFP-Pfn1 H133S. Myc-tag was included to all Pfn1 mutants because anti-GFP 
antibody recognizes both CFP and YFP, thus preventing the specificity of immunoprecipitation. 
Addition of myc-tag allowed for discrimination between YFP-Pfn1 and CFP-VASP. A positive 
control of YFP-Pfn1-CFP (YPC) was also created to force a strong intramolecular FRET signal. 
Figure 4b shows the constructs after transient transfection in HEK293 cells.  
To confirm in vivo binding of CFP-VASP and myc-YFP-Pfn1, the constructs were co-
expressed in HEK293 cells by transient transfection. As a negative control, either CFP-VASP 
was co-expressed with myc-YFP-Pfn1-H133S or CFP with myc-YFP-Pfn1. Anti-myc 
immunoprecipitates, when probed with GFP antibody, show that CFP-VASP co-precipitated 
with myc-YFP-Pfn1 as expected (Figure 5). This is due to interaction between VASP and Pfn1 
since CFP-VASP failed to co-precipitate with the H133S mutant form of Pfn1 and CFP did not 
co-precipitate with myc-YFP-Pfn1 which rules out the possibility of CFP-YFP heterodimer 
formation. These immunoprecipitation results also confirm that addition of CFP or YFP tags still 
allows in vivo interaction between Pfn1 and VASP. 
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Figure 4. Creation of FRET constructs. (a) Schematic diagram of various FRET constructs. (b) GFP-




Figure 5. Co-IP of FRET constructs. Myc-YFP-Pfn1 or H133S mutant co-expressed with either CFP or CFP-
VASP in HEK293 cells. When immunoprecipitated with anti-myc and probed with GFP antibody, only 
binding between CFP-VASP and myc-YFP-Pfn1. 
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4.1.2 Spectral FRET of Pfn1:VASP  
Next, to see whether Pfn1:VASP interaction can be resolved using spectral FRET, the 
constructs were again co-expressed as before in HEK293 cells. As additional negative controls, 
CFP-VASP was expressed alone and CFP was co-expressed with YFP-Pfn1. As a positive 
control, YPC was expressed alone in HEK293 cells. Cell suspension was excited at 425 nm 
wavelength (maximum excitation wavelength for CFP) and resultant emission spectrum over 
wavelength range of 460 to 600 nm was obtained at 5 nm intervals. Figure 6a shows the emission 
spectra data from the different groups. Cells expression CFP-VASP only showed one peak at 470 
nm as expected while cells expressing both CFP-VASP and myc-YFP-Pfn1 showed two peaks at 
465 and 520 nm wavelength (this was determined to be the FRET signature as it was seen in the 
positive control YPC expressing group). The two peaks were not detected in cells co-expressing 
CFP-VASP and myc-YFP-Pfn1-H133S. Cells in a suspended nature however do not mimic 
natural condition for cells which are non-hematopoietic, i.e. HEK293 cells. To investigate 
whether adherent vs. suspended states has any influence on Pfn1:VASP interaction in cells, GFP-
Pfn1 was expressed in HEK293 cells and endogenous VASP binding via immunoprecipitation of 
GFP-Pfn1 was examined between cells in adherent and suspended states. Figure 6b shows that 
VASP:Pfn1 interaction decreases greatly when cell-substrate adhesion is lost. Thus, the spectral 
FRET signal between CFP-VASP and YFP-Pfn1 is likely an underestimation of the actual 





Figure 6. Spectral FRET of FRET constructs in suspension. (a) Emission spectra of cells expression various 
FRET constructs under 425 nm excitation wavelength. FRET peak is shown by the arrow. Cells expressing 
the positive control YPC or co-expressing CFP-VASP and myc-YFP-Pfn1 show evidence of spectral FRET 
(all intensity values are normalized with the peak value at around 465-470 nm). (b) VASP blot (top panel) 
shows a remarkable difference in binding of endogenous VASP to GFP-Pfn1 via IPs between suspension 
(susp) and adherent (adh) states of HEK293 cells. GFP blot (bottom panel) is acting as a loading control for 
TCL and IP samples (TCL—total cell lysate; IP—immunoprecipitation). 
4.1.3 FRET between Pfn1 and VASP is detected at membrane ruffles near leading edge 
In order to determine if visualization of Pfn1:VASP interaction is possible in cells, we 
chose MDA-MB-231 (MDA-231) breast cancer cells which are highly motile and display a 
polarized (defined front and rear) morphology in culture. Since endogenous Pfn1 may compete 
with CFP-VASP binding and lower FRET signal, experiments were conducted on MDA-231 
stably expressing Pfn1-shRNA or luc-shRNA (control). Figure 7a immunoblot shows strong 
suppression of endogenous Pfn1 in Pfn1-shRNA expressing groups. As previously stated, all 
Pfn1 constructs are mutated in the silencing targeting region of siRNA or shRNA so that it will 
not be affected. Using acceptor photobleaching FRET (where YFP is the acceptor and CFP is the 
donor) we show in Figure 7b pre- and post-bleach CFP- and YFP-channel images of Pfn1-
shRNA MDA-231 cells co-expressing CFP-VASP with either YFP-Pfn1 or YFP-Pfn1-H133S. 
The region boxed for the YFP channel shows region where YFP bleaching occurred and thus 
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lower YFP expression. When the CFP expression was compared between CFP-VASP/YFP-Pfn1 
group and CFP-VASP/YFP-Pfn1-H133S group, we noticed that the pseudocolor plot intensity 
increased for YFP-Pfn1 co-expressed with CFP-VASP and not for the other. The lack of change 
in intensity for CFP-VASP/YFP-Pfn1-H133S was expected as the H133S mutation prevents 
binding of Pfn1 with PLPs, thus no FRET. Figure 8c shows the quantification of intensity change 
(~20% positive increase with CFP-VASP co-expressed with YFP-Pfn1 vs. -.8% for CFP-VASP 
co-expressed with YFP-Pfn1-H133S). A negative change in intensity is not unusual as it may 
occur from repetitive fluorescence imaging and thus photobleaching of flurophores [Karpova et 
al., 2003]. 
Next, to determine sub cellular localization of Pfn1:VASP interaction, acceptor 
photobleaching was performed on a whole cell level. Pseudocolor plots (Figure 8) of co-
expressing CFP-VASP and YFP-Pfn1 in CFP channel show increase in CFP-fluorescence on 
membrane ruffles of protruding lamellipod (shown with arrows) and in a somewhat diffuse 
fashion in the perinuclear region (shown with arrowhead). YFP-fluorescence partially decreased 
post bleaching as desired (Figure 8 upper panel). In order to determine that successive imaging 
was not the cause of CFP intensity increase, CFP and YFP images were taken in a similar 
fashion as for photobleaching except photobleaching was not performed. As shown by the 
bottom panel of Figure 8, CFP intensity increase was not due to successive image acquisition.   
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Figure 7. Visualization of Pfn1:VASP interaction using acceptor photobleaching FRET. (a) Pfn1 immunoblot 
of TCL extracted from wild type and various stable shRNA-expressers of MDA-231 cells depicting strong 
suppression of endogenous Pfn1 expression in Pfn1-shRNA expressers (luc—luciferase acts as a control for 
shRNA). GAPDH blot serves as the loading control. (b) Pre- and post-bleach images of MDA-231 co-
expressers of either CFP-VASP/YFP-Pfn1 or CFP-VASP/YFP-Pfn1-H133S in CFP and YFP channels (boxes 
outline the region of bleaching and insets show pseudocolor plots of the bleached region). (c) A box and 
whisker plot comparing the average FRET efficiency between the two test conditions (n—number of analyzed 
cells pooled from 2 to 3 experiments; ex: excitation, em: emission; bar—20 µm). 
 27 
 
Figure 8. FRET occurs at the membrane ruffles near the leading edge. Pseudocolor plots of CFP and YFP 
images from cell co-expression CFP-VASP and YFP-Pfn1 pre- and post-photobleaching of the whole cell (Top 
panel depicts representative image of 10 cells). Arrows indicate FRET at membrane ruffles. Arrowhead 
shows some diffuse FRET in the perinuclear region. Bottom panel shows a cell that is not photobleached but 
imaged successively as before (representative image of 3 cells) (ex: excitation; em: emission; bar—20 µm). 
4.2 DISCUSSION 
Much work has been done thus far in the field to elucidate the role of Pfn1 in cell 
migration. Pfn1’s role however is dynamic and depends on the system being investigated, for 
example in invasive breast cancer cells, silencing Pfn1 increases cell motility while 
overexpression leads to a reduction in cell motility while in human endothelial cells, silencing 
Pfn1 leads to defects in migration [Roy et al., 2004; Ding et al., 2006; Zou et al., 2007; Bae et al., 
2009]. Interaction between Pfn1 and PLPs has been shown previously to be important for cell 
migration [Ding et al., 2006; Ding et al., 2009]. Specific interaction between Pfn1 and PLPs 
regarding spatial interaction has not been investigated previously however. In this study, we 
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show the spatial interaction between Pfn1 and one of its PLP binding partners VASP using 
FRET.  
In terms of analyzing FRET, the most widely adopted method is measuring acceptor 
emission after donor excitation. This method has some drawbacks such as bleed-through of 
donor emission into the acceptor channel and cross-excitation of acceptor molecule by donor 
excitation wavelength. Mathematical correction would be required to convert raw FRET images 
to real FRET images. These issues become significant if the FRET signal is low because the 
signal can be masked by donor bleed-through and/or acceptor cross excitation, particularly with 
CFP- and YFP- based models due to the large spectral overlap of the two. To overcome this 
issue, acceptor photobleaching FRET was used. This technique relies on the fact that energy 
transfer between donor and acceptor is reduced when the acceptor is photobleached which causes 
an increase of emission for the donor. This method does not require any rigorous image 
correction via mathematics like conventional FRET imaging and is also better for investigating 
protein-protein interaction as fluorescence is generally decreased through photobleaching 
anyways unless there is FRET [Karpova et al., 2003]. As shown earlier, FRET was indeed 
detected by CFP-VASP/YFP-Pfn1 co-expressers and not by CFP-VASP/YFP-Pfn1-H133S co-
expressers. One downside to acceptor photobleaching is attempting to photobleach live cells. 
Heavy laser exposure might kill cells while trying to photobleach the acceptor. 
From the whole cell bleaching images, FRET seemed to occur at the membrane ruffles in 
the protruding lamellipod and somewhat in a diffuse fashion in the perinuclear region. Leading 
edge membrane ruffles are areas of high actin dynamics. For example, fibroblasts have shown 
that Ena/VASP activity leads to increased rates of membrane protrusion but these protrusions 
tend to be unstable and are retracted frequently [Bear et al., 2002]. Unproductive protrusions 
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cause membrane ruffles most of the time. Due to this, it is not unlikely that Pfn1:VASP 
interaction would be seen at the ruffles. Why Pfn1:VASP FRET is occurring in the perinuclear 
region is unclear.  
To summarize, we were able to elucidate using an intermolecular FRET technique the 
spatial interaction of Pfn1 with one of its key PLP partner VASP. Despite the usefulness of 
acceptor photobleaching with spatially resolving protein-protein interaction in cells, acceptor 
photobleaching is not able to demonstrate dynamics of interaction. Future experiments should 
consider fluorescence lifetime imaging measurements (FLIM)-based FRET technique to look at 
spatiotemporal dynamics of Pfn1:VASP interaction during cell migration. Now that Pfn1:VASP 
interaction has been shown, the next question is the effects of the interaction. This will be looked 
into with Specific Aim 2.  
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5.0  ROLE OF ENA/VASP:PFN1 INTERACTION IN CELL MIGRATION  
Previous studies have shown that Pfn1 enhances the actin polymerizing and anti capping aspect 
of VASP [Barzik et al., 2005; Hansen et al., 2010]. The polyproline domain of VASP was also 
demonstrated to be necessary for Listeria motility but not as necessary for whole cell migration 
for at least fibroblasts. In vivo importance of Ena/VASP and Pfn1 interaction are not well 
described however. In addition, previous studies on polyproline domain of VASP involved 
deletion of the polyproline domain which not only abrogates binding to Pfn1, but also potentially 
affects interaction with SH3- and WW-domain containing proteins. Thus, the role of Pfn1’s 
interaction in Ena/VASP-mediated regulation of cell migration must be specifically examined  
 
Specific Aim 2: Determine whether Ena/VASP’s effect on cell motility is influenced by 










5.1.1 Mena/VASP knockdown negatively regulates cell migration 
 
To address whether Ena/VASP proteins play a role in MDA-231 cell motility, I 
performed silencing experiments where VASP and Mena, two important members of Ena/VASP 
protein family, were transiently knocked down either selectively or in combination (as control, 
cells were transfected with non-targeting control siRNA). Immunoblot data in Fig 9a shows 
strong suppression of Mena and VASP expression in MDA-231 cells after respective siRNA 
treatment. I first analyzed the phenotypes of these different groups of cells by phase-contrast 
microscopy. Interestingly, a significant fraction (~50%,) of Mena/VASP knockdown cells 
displayed a highly elongated morphology lacking a robust lamellipodia (Figures 9b and 9c). This 
phenotype was also seen in cells subjected to either VASP or Mena knockdown, but not as 
pronounced as seen in cells with dual knockdown of Mena and VASP. Mena knockdown seemed 
to elicit a stronger phenotype than VASP knockdown in terms of suppressing lamellipodial 
formation in MDA-231 cells. Overall, these data are consistent with Ena/VASP’s role in 
lamellipodial protrusion. 
I next determined random motility of MDA-231 cells following Mena and VASP 
knockdown, the results of which are shown in Figure 9d.  VASP knockdown alone had no effect 
on the average speed of randomly migrating MDA-231 cells. Silencing Mena alone reduced the 
average speed by about 15% (p<0.05). Even though dual suppression of Mena and VASP 
induced a strong morphological phenotype, surprisingly, the average speed was only moderately 
affected. Silencing Mena and VASP reduced the average speed by only 25% (p<0.01). The 
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impaired speed was partly due to some cells not migrating when there were many elongated 
lamellipodia. I did not find any statistical difference in the average speed between Mena- and 
Mena/VASP- knockdown groups.   
 
 
Figure 9. Mena/VASP knockdown slightly reduces motility. (a) Immunoblot of ctrl, VASP, Mena, and 
Mena/VASP siRNA MDA-231 cells. Vimentin is used as a loading control. (b) Representative images from 
four siRNA groups. Lamellipodial defect phenotype indicated by arrows. (c) Bar graph representing number 
of elongated lamellipodia cells (n represents total number of cells from three experiments). (d) Box and 
whisker plot representing average speed of ctrl, VASP, Mena, and Mena/VASP siRNA groups. Asterisk and 





5.1.2 VASP overexpression reduces average migration speed in MDA-231  
Since Mena/VASP knockdown failed to induce a dramatic change in the random motility 
of MDA-231 cells, I next studied the effect of VASP overexpression on MDA-231 cell motility. 
I created a stable subline of MDA-231 cells overexpressing GFP-VASP. Immunoblot of total 
lysate derived from MDA-231 sublines expressing either GFP-VASP or GFP (control) showed 
about 3.5 fold overexpression of VASP in GFP-VASP expressers (note that endogenous VASP 
expression level is unchanged). Single-cell random motility assay was then conducted to 
determine the effect of VASP over-expression, the results of which are shown in Figure 10.  
GFP-VASP overexpression caused a 2-fold reduction in the migration speed. GFP-VASP 
overexpressers also seemed to be 50% less persistent in their direction of motility compared to 
GFP expressers (Figure 11). Overall, GFP-VASP overexpressers showed a tendency to initiate 
more frequent protrusions in random directions than GFP expressers which could very well 
explain reduced persistence of motility for this cell line. Finally, to confirm that VASP 
overexpression induced suppression of MDA-231 motility is not due to a clonal artifact, I 
examined the effect of transient overexpression of GFP-VASP on the random motility of MDA-
231 cells (control cells were transiently transfected with GFP-encoding plasmid). The 
experimental outcome (i.e., ~2-fold reduction in speed caused by VASP overexpression) (Figure 




Figure 10. VASP overexpression reduces motility. (a) GFP (left panel) and VASP (right panel) immunoblot of 
stably transfected GFP and GFP-VASP MDA-231 over-expressers. (b) A box and whisker plot comparing the 
average speed of stable GFP and GFP-VASP MDA-231 cells (n—number of analyzed cells pooled from 3-4 
experiments). All results are normalized to mean stable GFP speed. Double asterisks represent P<.01 (c) A 






Figure 11. Persistence is reduced in VASP overexpressing cells. (a) Bar graph depicting persistence (per 













5.1.3 VASP and Pfn1 interaction is required for negative regulation of cell motility 
I next asked whether VASP overexpression induced impaired motility of MDA-231 
requires interaction with Pfn1. To address this question, I re-evaluated the motility of GFP and 
GFP-VASP overexpressers either in wild-type or a polyproline binding deficient mutant Pfn1 
background. These two Pfn1 backgrounds were created by silencing endogenous Pfn1 expression 
and then rescuing with either wild-type or H133S mutant (this mutant of Pfn1 fails to bind 
polyproline and thus does not interact with VASP) of CFP-Pfn1. Figure 12b shows that when 
GFP-VASP is overexpressed in H133S-Pfn1 background, it only causes a 20% reduction in the 
speed compared to 50% reduction seen in wild-type Pfn1 background. In a complementary set of 
experiments, I transiently transfected MDA-231 with GFP, GFP-VASP or GFP-VASP-
P120E/L210E (a mutant form of VASP where the regulatory and loading site have been mutated 
to significantly reduce VASP’s binding to Pfn1) and examined the motility. Figure 12c shows 
that this mutant form of VASP is less efficient than wild-type VASP (24% vs. 50%) in terms of 
suppressing random motility of MDA-231 cells.  Together these two sets of experimental data 





Figure 12. VASP requires interaction with Pfn1 to negatively regulate cell motility. (a) Pfn1 immunoblot of 
ctrl and Pfn1 siRNA stable MDA-231 cells. Vimentin represents a loading control. (b) Box and whiskers plot 
of ctrl vs. Pfn1 knockdown in stably expressing GFP or GFP-VASP MDA-231 with either CFP-Pfn1 or CFP-
Pfn1-H133S rescued. (n represents number of cells). Asterisk and double asterisk denote P<.05 and P<.01 
respectively. (c) Box and whiskers plot of random migration for transiently transfection GFP, GFP-VASP, 









Ena/VASP proteins have been well characterized thus far as promoters of membrane 
protrusion through their role as an actin elongator [Rottner et al., 1999]. VASP has also been 
shown to increase the speed of Listeria movement intracellularly through the polyproline domain 
[Geese et al., 2002]. The polyproline domain of VASP was shown to be required for Listeria 
motility but not for whole cell migration, at least for fibroblasts. Studies on the polyproline 
domain of VASP however utilize a deletion of the region. Deletion of the polyproline domain not 
only abrogates binding to Pfn1 but also to SH3- and WW- domain which may cause further 
confounding data. This study aimed to identify key effects of VASP and Pfn1 interaction on cell 
migration using complementary mutation on VASP for the first time. 
We found that a significant fraction of cells following Mena/VASP knockdown assumed 
an elongated morphology lacking proper lamellipodia. This is consistent with the role of 
Ena/VASP in membrane protrusion. With only VASP silenced, there was no noticeable 
difference of random motility between ctrl and VASP siRNA groups. VASP is only one of three 
members in the Ena/VASP family however. By silencing VASP, a phenotype may not be 
induced because of the possibility that the other two members may compensate for the lack of 
VASP. Silencing Mena and VASP led to a slight reduction of motility. Average speed of 
migration may be reduced because silencing Mena and VASP removes a majority of F-actin 
elongators. The phenotype created by Mena/VASP knockdown may also be minor due to an 
incomplete knockdown of Mena and VASP. In addition, EVL is still present in the cell and may 
compensate for the lack of Mena and VASP.  
Since VASP knockdown alone did not produce a phenotype, I pursued the effect of 
VASP overexpression. Migration assays were conducted on stable GFP and GFP-VASP 
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overexpressing MDA-231 cells. Both stable expressing and transiently transfected groups 
showed a reduced speed in random motility when GFP-VASP was overexpressed. VASP has 
been implicated as an anti-cappper. Thus, when VASP is overexpressed, the net anti-capping 
action of VASP is expected to increase. Capping proteins act to prevent unwanted or 
unproductive F-actin elongation. Unproductive protrusion can lead to counteractive protrusion 
which leads to less net distance travelled for cells. As an F-actin elongator and capping protein 
antagonizer, overexpressed VASP would be expected to create longer actin filaments. In 
addition, overexpression of VASP could increase side binding of VASP to actin filaments. This 
may prevent binding of Arp2/3 to the sides of filaments and reduce branching of filaments. Long 
actin filaments tend to buckle more and this causes a protrusion to withdraw. Overall, 
overexpression of VASP and knockdown of Mena/VASP reduced random motility of MDA-231, 
thus suggesting that too much or too little Ena/VASP may be detrimental to random motility.  
I next investigated the role of VASP:Pfn1 interaction. I performed a silence and rescue of 
Pfn1 levels with either Pfn1 or Pfn1-H133S. The H133S mutant form of Pfn1 prevents Pfn1 from 
interacting with PLPs. With the rescue experiment, I show that once again VASP down 
regulation of random motility is reduced without interaction with Pfn1. The complementary 
experiment is a novel way to investigate VASP:Pfn1 interaction and does not utilize the deletion 
of the polyproline region. By only mutating key amino acids of the Pfn1 binding sites on VASP, 
SH3- and WW-domains are preserved. Mutation of the regulatory site and loading site caused a 
recovery of motility similar to the effects of Pfn1-H133S rescue. While VASP does not require 
Pfn1 to function, interaction with Pfn1 enhances the abilities of VASP [Barzik et al., 2005; 
Hansen et al., 2010].  Through the Pfn1 binding sites of VASP, VASP is able to recruit actin to 
the growing ends of F-actin through Pfn1. With the H133S mutant or mutant form of VASP, 
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Pfn1 can no longer bind to VASP, thus reducing its elongation abilities. Pfn1 can still shuttle 
actin to the leading edge however without interaction with VASP which may explain why 
motility was not fully recovered.  
In essence, this study showed the effects of VASP overexpression or silencing on MDA-
231 random motility. I also showed that Pfn1:VASP negatively regulates random migration 
speed of MDA-231. Future experiments should work to determine actin dynamics along with 
Pfn1:VASP interaction. Further work should also be performed to determine which polyproline 
site is the most important for cell migration.  
 
 41 
6.0  CONCLUSIONS 
The work presented here further clarifies the relationship between VASP and Pfn1 in cell 
migration. Using acceptor photobleaching FRET, I have shown that Pfn1:VASP interaction 
occurs near the leading edge of motile MDA-231 cells. This answers the question of spatial 
interaction between Pfn1 and VASP which biochemical methods in the past could not show. 
While acceptor photobleaching FRET is useful for determining protein-protein interaction, this 
technique cannot show dynamics of the interaction. Furthermore, this study showed that VASP 
indeed plays a role in cell migration (at least in MDA-231). Overexpression of VASP reduces 
motility most likely through its role as an anti-capper. By overexpressing VASP, less capping 
protein will be bound to growing ends of F-actin. This prevents capping of unwanted protrusions 
and leads to counteractive actin polymerization. Finally, using a rescue system and a novel 
VASP mutation expression, I demonstrated that VASP was not able to reduce motility as well 
without its binding partner Pfn1 which means that VASP and Pfn1 negatively regulate cell 
migration. In essence, this study further clarifies the in vivo effects of VASP:Pfn1 interaction in 
motile MDA-231 cells. 
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6.1 FUTURE DIRECTION 
This study showed that VASP and Pfn1 interaction played a negative regulatory role in 
cell migration. But how VASP:Pfn1 interaction inhibits cell motility remains to be identified.  
Future studies should be conducted to determine whether abolishing VASP:Pfn1 interaction 
alters the overall architrecture of actin filaments in the lamellipodia, actin dynamics at the 
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